U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07593872) titled 'XR-Assisted PET/CT Navigation for Cervical Lymph Node Dissection in Lung Cancer' on May 10.
Brief Summary: This single-arm, prospective feasibility study evaluates an Extended Reality (XR) headset-based preoperative surgical planning workflow that fuses 18F-FDG PET metabolic hotspots with CT anatomy on the OpVerse platform, in patients with non-small cell lung cancer (NSCLC) and supraclavicular or cervical lymph node metastasis (N3 disease) requiring lymph node dissection. Ten participants will undergo standard preoperative contrast-enhanced CT and whole-body PET. Synapse 3D software is used to segment key anatomic structures (clavic...